Objective To develop criteria for the classification of macrophage activation syndrome (MAS)
in patients with systemic juvenile idiopathic arthritis (JIA). Methods A multistep process, …

Objective To compare the safety and efficacy of parenteral methotrexate (MTX) at an intermediate
dosage (15 mg/m 2 /week) versus a higher dosage (30 mg/m 2 /week) in patients with …

… Sheila Knupp Feitosa de Oliveira Instituto de Puericultura e Pediatria Martagao Gesteira,
Rio de Janeiro, Brazil … Sheila Knupp Feitosa de Oliveira …

… Sheila Knupp Feitosa de Oliveira Instituto de Puericultura e Pediatria Martagao Gesteira,
Rio de Janeiro, Brazil … Sheila Knupp Feitosa de Oliveira …

… Ilowite,6 Isabelle Kone-Paut,7 Sheila Knupp Feitosa de Oliveira,8 Deborah McCurdy,9
Clovis Artur Silva,10 Flavio Sztajnbok,11 Elena Tsitsami,12 Erbil Unsal,13 Jennifer E. Weiss,14 …

In 2012, a European initiative called Single Hub and Access point for paediatric
Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and …

Objective In pivotal trials, canakinumab has been shown to be effective in the treatment of
systemic juvenile idiopathic arthritis (JIA), but reported adverse events have included …

Objective To develop and validate a diagnostic score that assists in discriminating primary
hemophagocytic lymphohistiocytosis (pHLH) from macrophage activation syndrome (MAS) …

Background: To date there are no specific classification criteria for childhood-onset systemic
lupus erythematosus (cSLE). This study aims to compare the performance among the …

Juvenile systemic sclerosis (JSSc) is a rare disease of childhood and currently no international
consensus exists with regard to its assessment and treatment. This SHARE (Single Hub …